First-neighbor specificities of actinomycin-DNA bindings by circular dichroism

Understanding how small molecules bind to DNA is essential for drug development and molecular biology. Circular dichroism (CD) spectroscopy has been used to study DNA structure and interactions. CD is sensitive to the arrangement of adjacent nucleotides, making it useful for detecting changes in DNA caused by binding agents. Prior research has shown that CD spectra can reflect the nearest-neighbor composition of DNA. However, the specific first-neighbor sequences that interact with certain drugs remain unclear. This gap motivated researchers to investigate how actinomycin interacts with DNA. Actinomycin is known to intercalate into DNA, but the exact sequences it targets were not fully resolved. The study aimed to identify these sequences using CD spectroscopy. By analyzing a range of DNA samples, including natural and synthetic ones, the researchers sought to map actinomycin's binding preferences. This work builds on existing knowledge of DNA structure and drug interactions.

The study aimed to determine the first-neighbor specificities of actinomycin-DNA binding using circular dichroism. Actinomycin is a known DNA intercalator, but its preferred binding sites were not fully characterized. Researchers sought to identify which DNA sequences are most affected by actinomycin. They used CD spectroscopy to measure changes in DNA structure upon actinomycin binding. The goal was to map the specific first-neighbor units that are perturbed by the drug. By analyzing a diverse set of DNA samples, the researchers aimed to distinguish between favorable and unfavorable binding sites. This approach allowed them to separate intercalation sites into three distinct families. The study's findings could clarify how actinomycin interacts with DNA at the molecular level.

Researchers used circular dichroism spectroscopy to study DNA-actinomycin interactions. They measured CD spectra of eleven DNA samples across a range of wavelengths. Five natural DNAs with known nearest-neighbor frequencies were included. Six synthetic polydimers and polytrimers were also tested. Spectra were recorded in the absence and presence of increasing actinomycin concentrations. The drug was added until saturation was reached. Matrix analysis was applied to interpret the CD data. This method allowed the researchers to identify which first-neighbor units were affected by actinomycin binding.

The study revealed that actinomycin preferentially binds to certain first-neighbor DNA sequences. GpC and CpG units were identified as highly favorable binding sites. ApG, CpC, ApC, TpC, and TpG showed moderate binding affinity. In contrast, ApT, TpA, and ApA were found to be unfavorable sites. The CD spectra indicated that actinomycin intercalation alters these specific sequences. The results suggest that the drug's planar structure interacts with DNA in a sequence-dependent manner. The intercalation sites were grouped into three families based on binding strength. These findings provide a detailed map of actinomycin's DNA binding preferences.

The authors concluded that actinomycin's binding to DNA is sequence-specific. The drug preferentially intercalates into GpC and CpG units. Other sequences, such as ApG and CpC, showed lower binding affinity. ApT, TpA, and ApA were found to be unfavorable binding sites. The results suggest that the drug's planar structure interacts with DNA in a sequence-dependent manner. The study provides a detailed map of actinomycin's DNA binding preferences. These findings may help explain the drug's biological effects. The authors propose that these specificities could be used to design more targeted DNA-binding agents.